Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program
- Conditions
- PreDiabetes
- Interventions
- Behavioral: Noom Coach DPP
- Registration Number
- NCT03865342
- Lead Sponsor
- Noom Inc.
- Brief Summary
This study will test the weight loss efficacy of a mobile diabetes prevention program intervention. Half of the sample of prediabetic adults will receive the virtual DPP and half will receive usual medical care.
- Detailed Description
There were 84.1 million people with pre-diabetes, 30.3 million people with diagnosed and 7.2 million with undiagnosed diabetes in the United States in 2015, and nearly 2 million are diagnosed with it every year. By 2050, the CDC estimates that 1 in every 3 people globally will have diabetes, a leading cause of death and disability.
The primary goal of this study is to evaluate the efficacy of the Noom Coach Diabetes Prevention Program mobile platform versus usual medical care. The best intervention to date for prediabetes is the Centers for Disease Control and Prevention's Diabetes Prevention Program, yet there is limited research investigating a mobile-based delivery of the DPP. Pre-diabetes is often discovered during routine medical visitation/annual screening (usual care), but face-to-face time with clinicians is often limited. Exploring novel ways, such as mHealth interventions to empower patients to pursue lifestyle change and prevent or delay diabetes onset is critical to addressing the growing diabetes epidemic.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 202
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Noom Coach DPP Noom Coach DPP Individuals will receive special instructions on how to use the app and will self-monitor their weight, exercise and receive daily DPP core content through the app over 16 weeks plus guidance from a coach, and will thereafter receive post-core DPP content up to 52 weeks.
- Primary Outcome Measures
Name Time Method Change in weight Baseline, 6, and 12 months Body weight recorded during follow-up appointments at the medical clinic.
- Secondary Outcome Measures
Name Time Method Change in hemoglobin A1c Baseline, 6, and 12 months Hemoglobin A1c measured during follow-up appointments at the medical clinic.
Trial Locations
- Locations (1)
Stony Brook University
🇺🇸Stony Brook, New York, United States